Vifor Pharma AG Logo

Vifor Pharma AG

VIFN | SW

Overview

Corporate Details

ISIN(s):
CH0364749348
LEI:
529900KO6CN2D9OE1F19
Country:
Switzerland
Address:
Rechenstrasse 37, 9014 St. Gallen
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CSL Vifor is a global specialty biotechnology company focused on iron deficiency, nephrology, and rare diseases. A pioneer and global leader in iron-based therapies, the company develops, manufactures, and markets pharmaceutical products to address significant unmet medical needs. Its core therapeutic areas include iron deficiency anemia in conditions such as heart failure, kidney disease, gastroenterology, and women's health. In partnership with its joint company, Vifor Fresenius Medical Care Renal Pharma, CSL Vifor has a strong and growing presence in treating the full spectrum of kidney disease. The company's business model emphasizes strategic global partnering, in-licensing, and commercializing innovative therapies, with a presence in over 100 countries.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Vifor Pharma AG. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Vifor Pharma AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Vifor Pharma AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-03-09 N/A Executive member Sell None 4,335,210.00 CHF
2022-03-09 N/A Non-Executive member Sell None 1,951,125.00 CHF
2022-03-09 N/A Non-Executive member Sell None 1,851,300.00 CHF
2022-03-09 N/A Executive member Sell None 1,535,160.00 CHF
2022-03-09 N/A Non-Executive member Sell None 1,450,515.00 CHF
2022-03-09 N/A Executive member Sell None 920,205.00 CHF
2022-03-09 N/A Executive member Sell None 530,310.00 CHF
2022-03-09 N/A Non-Executive member Sell None 382,140.00 CHF
2022-03-09 N/A Non-Executive member Sell None 330,495.00 CHF
2022-03-09 N/A Executive member Sell None 287,925.00 CHF

Peer Companies

Company Country Ticker View
Navamedic Logo
Develops and supplies pharmaceuticals, consumer health goods, and hospital products in the Nordics.
Norway NAVA
Newbury Pharmaceuticals AB Logo
Markets specialty prescription drugs in Scandinavia for oncology, rare diseases, and neurology.
Sweden NEWBRY
New Nordic Healthbrands AB Logo
Develops and markets herbal supplements and natural beauty products on a global scale.
Sweden NNH
NIPPON CHEMIPHAR CO., LTD. Logo Japan 4539
Nippon Shinyaku Co.,Ltd. Logo Japan 4516
Noile-Immune Biotech Inc. Logo Japan 4893
Novacyt Logo
Designs and supplies molecular diagnostic tests and PCR kits for human, veterinary, and food safety.
France ALNOV
Novartis AG Logo
Researches and develops patented and generic medicines for areas of high medical need.
Switzerland NOVN
Novo Nordisk Logo
Develops medicines and devices for chronic diseases like diabetes, obesity, and rare disorders.
Denmark NOVO
NUTEX Investments Plc Logo
Develops & distributes health, cosmetic & pharma products from natural ingredients globally.
Hungary NUTEX